Kirkland Advises Cinven on Sale of Minority Stake in SYNLAB to Labcorp
September 20, 2024
September 20, 2024
CHICAGO, Illinois, Sept. 20 -- Kirkland and Ellis, a law firm, issued the following news release:
Kirkland & Ellis has advised Cinven on the sale of an indirect minority stake in SYNLAB to strategic investor Labcorp. The completion of the sale is subject to regulatory approvals and is expected to occur in Q1 2025.
SYNLAB is one of the leading European clinical laboratory and medical diagnostic services companies and has more than 27,000 employees in over 30 countrie . . .
Kirkland & Ellis has advised Cinven on the sale of an indirect minority stake in SYNLAB to strategic investor Labcorp. The completion of the sale is subject to regulatory approvals and is expected to occur in Q1 2025.
SYNLAB is one of the leading European clinical laboratory and medical diagnostic services companies and has more than 27,000 employees in over 30 countrie . . .